|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Institute on Drug Abuse (NIDA) |
|---|---|
| Collaborator: |
Columbia University |
| Information provided by: | National Institute on Drug Abuse (NIDA) |
| ClinicalTrials.gov Identifier: | NCT00000200 |
Purpose
The purpose of this study is to compare the effects of buprenorphine or methadone maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving, in opiate-dependent cocaine users.
| Condition | Intervention | Phase |
|---|---|---|
|
Cocaine-Related Disorders |
Drug: Methadone |
Phase II |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver), Active Control, Single Group Assignment, Safety/Efficacy Study |
| Official Title: | Cocaine Effects in Humans: Physiology and Behavior |
| Enrollment: | 19 |
| Study Start Date: | January 1997 |
| Study Completion Date: | January 1998 |
| Primary Completion Date: | January 1998 (Final data collection date for primary outcome measure) |
Eligibility| Ages Eligible for Study: | 18 Years to 45 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Please contact site for information.
Contacts and Locations
More Information
| Study ID Numbers: | NIDA-03818-1, R01-03818-1 |
| Study First Received: | September 20, 1999 |
| Last Updated: | September 10, 2008 |
| ClinicalTrials.gov Identifier: | NCT00000200 History of Changes |
| Health Authority: | United States: Federal Government; United States: Food and Drug Administration |
|
Cocaine-Related Disorders Respiratory System Agents Physiological Effects of Drugs Disorders of Environmental Origin Central Nervous System Depressants Narcotics Pharmacologic Actions Methadone Sensory System Agents |
Mental Disorders Therapeutic Uses Substance-Related Disorders Peripheral Nervous System Agents Analgesics Antitussive Agents Central Nervous System Agents Analgesics, Opioid |